Bayer Hires Counsel To Look At Trasylol Disclosure
Bayer AG has appointed independent counsel to review the company's failure to disclose to the U.S. Food and Drug Administration a study that revealed health risks posed by its heart surgery...To view the full article, register now.
Already a subscriber? Click here to view full article